about
PKC-epsilon is upstream and PKC-alpha is downstream of mitoKATP channels in the signal transduction pathway of ischemic preconditioning of human myocardiumThe impact of continuous haemofiltration with high-volume fluid exchange during cardiopulmonary bypass surgery on the recovery of patients with impaired renal function: a pilot randomised trial.One problem two issues! Left ventricular systolic and diastolic dysfunction in aortic stenosisFree radicals in blood: evolving concepts in the mechanism of ischemic heart disease.NO-cGMP and TNF-alpha counter regulatory system in blood: understanding the mechanisms leading to myocardial dysfunction and failure.Deleterious effects of cardiopulmonary bypass in coronary artery surgery and scientific interpretation of off-pump's logic.Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease.Levosimendan versus an intra-aortic balloon pump in adult cardiac surgery patients with low cardiac output.Issues in online patient self-reporting of health status.A review of interventions to improve enrolment and attendance to cardiac rehabilitation among patients aged 65 years or above.The Impact of Diabetes on Mortality Among Elderly Patients Admitted for Treatment at a Hospital for Cardiovascular Disease in Southern Brazil.A Single-Center Randomized Trial of Intraoperative Zero-Balanced Ultrafiltration During Cardiopulmonary Bypass for Patients With Impaired Kidney Function Undergoing Cardiac Surgery.The impact of social deprivation on coronary revascularisation treatment outcomes within the National Health Service in England and Wales.Protein nitration is predominantly mediated by a peroxynitrite-dependent pathway in cultured human leucocytes.Nitric Oxide-Dependent Regulation of Cytokines Release in Type-II Diabetes Mellitus.Ex vivo complement protein adsorption on positively and negatively charged cellulose dialyser membranes.A pilot randomised controlled trial in intensive care patients comparing 7 days' treatment with empirical antibiotics with 2 days' treatment for hospital-acquired infection of unknown origin.Ethnicity and adverse operative outcomes among Australian patients undergoing first-time isolated coronary artery bypass graft surgery.Serum gamma glutamyl transferase: a novel biomarker for screening of premature coronary artery disease.Website design: technical, social and medical issues for self-reporting by elderly patients.Gender differences in the expression of genes involved during cardiac development in offspring from dams on high fat diet.An intervention for pulmonary rehabilitators to develop a social identity for patients attending exercise rehabilitation: a feasibility and pilot randomised control trial protocol.A variant of position −308 of the Tumour necrosis factor alpha gene promoter and the risk of coronary heart diseaseIn vitro contact phase activation with haemodialysis membranes: role of pharmaceutical agentsBiomaterials in cardiopulmonary bypassMyocardial protection against ischemia-reperfusion injury: novel approaches in maintaining homeostatic stability in bloodInspired nitric oxide and modulation of oxidative stress during cardiac surgeryIn Situ Oxidative Stress and Atrial Cell Deaths in Patients with Valve DiseaseProportional weight loss in six months as a risk factor for mortality in stage IV non-small cell lung cancerImpact of a community-based cardiovascular disease service intervention in a highly deprived areaNeutrophil Gelatinase-associated Lipocalin as a Marker of Postoperative Acute Kidney Injury Following Cardiac Surgery in Patients with Preoperative Kidney Impairment
P50
Q28275661-7C6AC3C9-E769-46CA-AE47-EE712FC01F7CQ30355099-3B6468C2-5AB3-4B09-AEEF-F89C8E67C208Q34357901-A18271A2-69C2-4B0B-B3AA-FF419D54A14FQ36451966-7A38FFF7-96FE-4249-A99B-2929AE3BA8ADQ36625398-173634ED-CC71-4742-8AA2-B275881187BAQ36680687-07A587DE-584F-46D9-A912-8DDA1C2EA26DQ37587099-07008AB1-D9F2-415C-A7B3-B06B83321AF5Q37849960-57F125E6-36F0-40A2-8213-6E6CDAA8EDFCQ38240932-A5C9389F-74C6-4DFB-9EE9-A8B17C96569CQ39430171-3F9D8EA2-E47C-4FAB-B839-58E40D555306Q40701997-696CA75C-9751-4DCE-B2E3-388CAA9E600FQ41135541-94576B9E-70EB-455C-9E50-465649839DBBQ41582076-C1289285-1192-45BE-9E79-C0C22CFC0830Q41787349-6497910C-56FF-43C5-B532-DD5C3D9202D1Q41791572-413290B5-129E-4E5F-B826-735F945FE12AQ42635038-39D52437-604F-449D-AB1B-7A4E95D2C35DQ42669679-2CDD8CA8-4EEF-4179-B9C8-7B7F138FB75EQ43740745-473C5AF8-AAD2-4379-A97E-4A080EA0A0C7Q45026246-622F6FBF-0E43-4B25-9529-937EFFD1C2B3Q48166268-A6CFE209-86FC-44FA-A631-A4D8A69F2918Q48641170-11A23ACE-7A6B-469E-AF39-91CAAC2961E8Q49554733-D5FC0C77-E742-4E62-97F2-C78CA268FA0BQ58466381-892573BF-45D8-47D3-9ACD-4DB781B38FB2Q70930412-314EDA29-9253-4432-9B0B-77A53462ECBCQ72372243-6321BB0F-F6B3-4EE5-AC10-64801A5117F9Q80551202-5494E794-39AD-40C8-BDE2-CB265F3EB589Q84078784-2ADC8546-7092-4454-B3BF-1C5D93D1CA32Q90397827-1688C07F-0BCC-49C3-A719-E7E3DFF556EFQ91377803-E097654F-F4B9-40BD-B95F-FF6D9F33438BQ92795104-B7FF1C0B-CE2A-470B-9742-95E2C1969B56Q93106982-AC625DE8-A5BB-43FE-8CBC-6205DD249073
P50
description
researcher
@en
wetenschapper
@nl
name
B M Matata
@en
B M Matata
@nl
type
label
B M Matata
@en
B M Matata
@nl
prefLabel
B M Matata
@en
B M Matata
@nl
P106
P31
P496
0000-0003-2896-8059